Archived Content

Speakers

Jane Barlow, M.D., Vice President, Clinical Innovation, Advanced Clinical Science and Research, Medco Health Solutions
Richard Bartfai, Ph.D., Postdoctoral Fellow, Molecular Biology, Nijmegen Center for Molecular Life Sciences, Radboud University Nijmegen
Michael Berndt, Ph.D., Professor, Director, Biomedical Diagnostics Institute
Dalia Cohen, Ph.D., CSO, Asterand
Allen Crook, Vice President, Pfizer
Jens Dhein, Ph.D., Scientific Director, Abbott Molecular
Sven Diederichs, Ph.D., Principal Investigator, Molecular RNA Biology & Cancer, German Cancer Research Center
Jens Ducrée, Ph.D., Associate Professor, Microsystems, Biomedical Diagnostics Institute, Dublin City University
Vincent C. Emery, Ph.D., Infection, School of Life and Medical Sciences (Royal Free Campus), University College London
Tanja Fehm, M.D., Ph.D., University of Tübingen
Vanya A. Gant, M.D., Ph.D., Director, Center for Infectious Diseases & International Health, University College London School of Medicine
Susan Garfield, Dr.P.H., Vice President, Bridgehead International
Luc Gervais, Ph.D., Swiss Federal Institute of Technology (EPFL)
Harry Glorikian, Managing Partner, Scientia Advisors
Andrew Gover, COO, Vantix, Ltd.
Dag Harmsen, M.D., Professor, Head of Research, Peridontology, University Münster
Syed Hashsham, Ph.D., Professor, Civil and Environmental Engineering, Michigan State University
Ansgar Hebborn, Ph.D., Head, Global Payer & HTA Program Policy, Global Health Economics & Pricing (GHEP), F. Hoffmann-La Roche AG
J.W. (Hans) Hofstraat, Ph.D., Vice President Philips Research, Healthcare Strategic Partnerships, Philips Research Laboratories
Alain Huriez, M.D., Founder and Chairman, European Personalized Medicine Association (EPEMED); CEO, TcLand Expression
Wolfgang Janni, M.D., Ph.D., Professor, Gynecological Clinic, Heinrich-Heine University Hospital Düsseldorf
Beatrice Knudsen, M.D., Ph.D., Medical Director, Biorepository and Translational Pathology, Cedars-Sinai Medical Center
Bernard LaScola, M.D., Ph.D., Faculty of Medicine, University of the Mediterranean, Marseille
Craig Lehmann, Ph.D., CC (NRCC), ASCP, FACB, Dean, School of Health Technology and Management; Professor, Clinical Laboratory Sciences, Stony Brook University
Ulrich Lehmann, Ph.D., Professor, Molecular Pathology, Hannover Medical School
Christopher R. Lowe, OBE, FREng, FInstP, FRSC, Director & Professor, Institute of Biotechnology, University of Cambridge
Daniel Mark, Ph.D., Deputy Division Head, Lab-on-a-Chip, HSG-IMIT
Andres Martínez, Chemistry & Biochemistry, California Polytechnic State University
Amy M. Miller, Ph.D., Public Policy Director, Personalized Medicine Coalition
Volkmar Müller, M.D., Ph.D., Department of Gynecology, University Medical Center Hamburg-Eppendorf
Rachael Natrajan, Ph.D., Postdoctoral Fellow, Molecular Pathology, Breakthrough Breast Cancer Centre
Andreas Nitsche, Ph.D., Head of Division of Highly Pathogenic Viruses, Robert Koch Institute
Diego Ossa, M.D., M.Sc., Head, Health Economics & Outcomes Research, Molecular Diagnostics, Novartis Pharma AG
Juliette Plun-Favreau, Director, Reimbursement & Market, Genomic Health
Jean-Yves Pierga, M.D., Ph.D., Medical Oncology, Institute Curie, Paris
Andreas Plueckthun , Ph.D., Professor, Biochemical Institute, University of Zurich
Peter Riegman, Ph.D., Head, Erasmus MC Tissue Research Support Unit, Department of Pathology, Josephine Nefkens Institute, Erasmus MC Rotterdam, The Netherlands; Chair, OECI WG European Biobanking; Vice President, ESBB
Michael H. A. Roehrl, M.D., Ph.D., Assistant Professor, Pathology and Laboratory Medicine, Boston Medical Center
Ajit Sadana, Ph.D., Professor, Chemical Engineering, University of Mississippi
Stefan Sauerland, M.D., M.P.H., Head, Department of Non-Drug Interventions, Institute for Quality and Efficiency in Healthcare (IQWiG)
Frank Schacherer, Ph.D., COO/CSO, BIOBASE GmbH
Lesley Scott, Ph.D., Professor, Molecular Medicine and Hematology, University of Witwatersrand
Kai Sohn, Ph.D., Molecular Biotechnology, Fraunhofer Institute for Interfacial Engineering and Biotechnology
Charles Swanton, Ph.D., Translational Cancer Therapeutics Laboratory, Cancer Research UK London Research Institute
Austin Tanney, Ph.D., Scientific Liaison Manager, Almac
Ali Tinazli, Ph.D., Director, Business Development & Sales, BioSciences, Sony DADC Austria AG
Chris Toumazou, Ph.D., CEO and Founder, DNA Electronics Ltd.
Adrian Towse, Director, Office of Health Economics, London
Peter Verhasselt, Principal Scientist, Translational Genomics and Genetics, Janssen Pharmaceutical Companies of Johnson & Johnson
Ruediger Weseloh, Ph.D., Senior Director, Head Strategic Transactions, Early-Stage Licensing, Merck KGaA
Stephen A. Williams, M.D., Ph.D., CMO, SomaLogic Inc.